(Q33358854)

26 July 2017

1 reference

title

Cancer and thrombosis: mechanisms and treatment (English)

1 reference

26 July 2017

0 references

Steven R Deitcher

1

1 reference

26 July 2017

1 August 2003

1 reference

Journal of Thrombosis and Thrombolysis

26 July 2017

1 reference

26 July 2017

16

1 reference

26 July 2017

1-2

1 reference

26 July 2017

21-31

1 reference

https://scigraph.springernature.com/pub.10.1023/b:thro.0000014589.17314.24

26 July 2017

0 references

cites work

Cancer and venous thromboembolism

1 reference

12 December 2020

Why shouldn't we use warfarin alone to treat acute venous thrombosis?

1 reference

12 December 2020

Deep venous thrombosis and pulmonary artery embolism in high-grade non Hodgkin's lymphoma: incidence, causes and prognostic relevance.

1 reference

12 December 2020

Deep vein thrombosis of the leg. Is there a "high risk" group?

1 reference

12 December 2020

Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis

1 reference

12 December 2020

Coagulation markers predict survival in cancer patients

1 reference

12 December 2020

Safety and efficacy of long-term oral anticoagulation in cancer patients

1 reference

12 December 2020

Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota

1 reference

12 December 2020

Efficacy and safety of oral anticoagulation in patients with cancer

1 reference

12 December 2020

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

1 reference

12 December 2020

Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group

1 reference

12 December 2020

Groshong catheter-associated subclavian venous thrombosis

1 reference

12 December 2020

The risk and efficacy of anticoagulant therapy in the treatment of thromboembolic complications in patients with primary malignant brain tumors

1 reference

12 December 2020

Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

1 reference

12 December 2020

The relationship between the thrombotic and infectious complications of central venous catheters

1 reference

12 December 2020

Cancer and venous thromboembolism: an overview

1 reference

12 December 2020

Inferior vena caval filters: review of a 26-year single-center clinical experience

1 reference

12 December 2020

Comparison of once-daily subcutaneous Fragmin with continuous intravenous unfractionated heparin in the treatment of deep vein thrombosis

1 reference

12 December 2020

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

12 December 2020

Low-molecular-weight heparins

1 reference

12 December 2020

The prethrombotic state in cancer

1 reference

12 December 2020

A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. Prévention du Risque d'Embolie Pulmonaire par Interruption Cave Study Group

1 reference

12 December 2020

Subcutaneous enoxaparin once or twice daily compared with intravenous unfractionated heparin for treatment of venous thromboembolic disease

1 reference

12 December 2020

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

12 December 2020

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism

1 reference

12 December 2020

Incidence and treatment of peripheral venous thrombosis in patients with glioma

1 reference

12 December 2020

Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data

1 reference

12 December 2020

Cancer cell procoagulants and their implications

1 reference

12 December 2020

A study of pulmonary embolism and deep leg vein thrombosis after major gynaecological surgery using labelled fibrinogen-phlebography and lung scanning

1 reference

12 December 2020

Acquired free protein S deficiency associated with multiple myeloma: a case report

1 reference

12 December 2020

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

12 December 2020

Heparin and angiogenesis: a low-molecular-weight fraction inhibits and a high-molecular-weight fraction stimulates angiogenesis systemically

1 reference

12 December 2020

The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial

1 reference

12 December 2020

Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study

1 reference

12 December 2020

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

12 December 2020

Therapy of venous thromboembolism in patients with brain metastases.

1 reference

12 December 2020

The efficacy and safety of oral anticoagulation in patients with cancer

1 reference

12 December 2020

Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety

1 reference

12 December 2020

The importance of initial heparin treatment on long-term clinical outcomes of antithrombotic therapy. The emerging theme of delayed recurrence

1 reference

12 December 2020

Monitoring warfarin therapy in patients with lupus anticoagulants

1 reference

12 December 2020

Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period

1 reference

12 December 2020

Hypercoagulable syndromes: evaluation and management strategies for acute limb ischemia

1 reference

12 December 2020

Deep Venous Thrombosis and Pulmonary Embolism

1 reference

12 December 2020

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

1 reference

12 December 2020

The Long-Term Clinical Course of Acute Deep Venous Thrombosis

1 reference

12 December 2020

Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis

1 reference

12 December 2020

A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin.

1 reference

12 December 2020

A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis

1 reference

12 December 2020

Risk of intracranial hemorrhage in glioma patients receiving anticoagulant therapy for venous thromboembolism

1 reference

12 December 2020

Treatment of deep vein thrombosis and pulmonary emboli in patients with primary and metastatic brain tumors. Anticoagulants or inferior vena cava filter?

1 reference

12 December 2020

Relation between the time to achieve the lower limit of the APTT therapeutic range and recurrent venous thromboembolism during heparin treatment for deep vein thrombosis

1 reference

12 December 2020

Pathogenesis of thrombosis in patients with malignancy.

1 reference

12 December 2020

Human tumor procoagulants: registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis.

1 reference

12 December 2020

Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors

1 reference

12 December 2020

Diagnosis of venous thromboembolic disease in cancer patients.

1 reference

12 December 2020

Antithrombotic therapy for venous thromboembolic disease

1 reference

12 December 2020

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

1 reference

12 December 2020

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

12 December 2020

Establishing a therapeutic range for heparin therapy

1 reference

12 December 2020

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

12 December 2020

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1

1 reference

12 December 2020

Treatment of thromboembolic complications in patients with brain tumors

1 reference

12 December 2020

Deep vein thrombosis and pulmonary embolism in the general population. 'The Study of Men Born in 1913'

1 reference

12 December 2020

Comparison of subcutaneous unfractionated heparin with a low molecular weight heparin (Fragmin) in patients with venous thromboembolism and contraindications to coumarin

1 reference

12 December 2020

Dosing in heavy-weight/obese patients with the LMWH, tinzaparin: a pharmacodynamic study

1 reference

12 December 2020

The effects of standard and low molecular weight heparin on bone nodule formation in vitro

1 reference

12 December 2020

Low molecular weight heparin versus warfarin in the prevention of recurrences after deep vein thrombosis

1 reference

12 December 2020

Upper-extremity deep vein thrombosis. Risk factors, diagnosis, and complications

1 reference

12 December 2020

Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement

1 reference

12 December 2020

A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats

1 reference

12 December 2020

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy.

1 reference

12 December 2020

Prevention of thrombotic disorders in cancer patients undergoing chemotherapy

1 reference

12 December 2020

Low-molecular-weight heparin in the treatment of patients with venous thromboembolism

1 reference

12 December 2020

Thrombosis: the major Hickman catheter complication in patients with solid tumor

1 reference

12 December 2020

The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group.

1 reference

12 December 2020

LGM (Vena Tech) vena caval filter: experience at a single institution

1 reference

12 December 2020

Superior vena cava syndrome: current concepts of management

1 reference

12 December 2020

Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis.

1 reference

12 December 2020

Diagnosis and treatment of cancer-related thrombosis

1 reference

12 December 2020

Vena caval filters: a comprehensive review.

1 reference

12 December 2020

1 reference

12 December 2020

Complications and failure of anticoagulation therapy in the treatment of venous thromboembolism in patients with disseminated malignancy

1 reference

12 December 2020

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

12 December 2020

Recurrent venous thrombosis and heparin therapy: an evaluation of the importance of early activated partial thromboplastin times.

1 reference

12 December 2020

Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy

1 reference

12 December 2020

Prevention of thromboembolism after neurosurgery for brain and spinal tumors.

1 reference

12 December 2020

Risk factors for bleeding during treatment of acute venous thromboembolism

1 reference

12 December 2020

A meta-analysis comparing low-molecular-weight heparins with unfractionated heparin in the treatment of venous thromboembolism: examining some unanswered questions regarding location of treatment, product type, and dosing frequency

1 reference

12 December 2020

Tissue factor expression in human leukocytes and tumor cells

1 reference

12 December 2020

Inferior vena cava filters in cancer patients: indications and outcome

1 reference

12 December 2020

Impaired resolution of massive pulmonary embolism associated with an inhibited fibrinolytic response

1 reference

12 December 2020

Treatment of patients with venous thromboembolism and malignant disease: should vena cava filter placement be routine?

1 reference

12 December 2020

Antithrombotic strategies in patients with cancer

1 reference

12 December 2020

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

12 December 2020

Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range

1 reference

12 December 2020

A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism.

1 reference

12 December 2020

Thrombotic complications of central venous catheters in cancer patients

1 reference

12 December 2020

Low-molecular-weight heparin versus warfarin for prevention of recurrent venous thromboembolism: a randomized trial

1 reference

12 December 2020

Treatment of deep venous thrombosis with low-molecular-weight heparins. A meta-analysis

1 reference

12 December 2020

Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.

1 reference

12 December 2020

Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials

1 reference

12 December 2020

10.1023/B:THRO.0000014589.17314.24

Identifiers

DOI

1 reference

PubMed ID

14760208

Dimensions Publication ID

26 July 2017

0 references

1 reference

PubMed ID

14760208